PIN1 inhibits apoptosis in hepatocellular carcinoma through modulation of the antiapoptotic function of survivin

American Journal of Pathology

Volumn 182, Issue 3, 2013, Pages 765-775

  Cheng, Chi Wai ^a   Chow, Ariel K M ^a   Pang, Roberta ^a   Fok, Elaine W S ^a   Kwong, Yok Lam ^a   Tse, Eric ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; CASPASE 9; PEPTIDYLPROLYL ISOMERASE PIN1; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SITE DIRECTED MUTAGENESIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER NEOPLASMS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; SUBCELLULAR FRACTIONS;

EID: 84874515089     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.11.034     Document Type: Article

References (31)

1. F.X. Bosch, J. Ribes, R. Cléries, and M. Díaz Epidemiology of hepatocellular carcinoma Clin Liver Dis 9 2005 191 211 v
2. R.W. Pang, and R.T. Poon From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now Oncology 72 Suppl 1 2007 30 44
3. K.P. Lu, Y.C. Liou, and X.Z. Zhou Pinning down proline-directed phosphorylation signaling Trends Cell Biol 12 2002 164 172
4. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 2001 355 365
5. K.P. Lu, S.D. Hanes, and T. Hunter A human peptidyl-prolyl isomerase essential for regulation of mitosis Nature 380 1996 544 547
6. R. Pang, J. Yuen, M.F. Yuen, C.L. Lai, T.K. Lee, K. Man, R.T. Poon, S.T. Fan, C.M. Wong, I.O. Ng, Y.L. Kwong, and E. Tse PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma Oncogene 23 2004 4182 4186
7. R.W. Pang, T.K. Lee, K. Man, R.T. Poon, S.T. Fan, Y.L. Kwong, and E. Tse PIN1 expression contributes to hepatic carcinogenesis J Pathol 210 2006 19 25
8. A. Ryo, H. Uemura, H. Ishiguro, T. Saitoh, A. Yamaguchi, K. Perrem, Y. Kubota, K.P. Lu, and I. Aoki Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer Clin Cancer Res 11 2005 7523 7531
9. L. Lv, Z. Zhou, X. Huang, Y. Zhao, L. Zhang, Y. Shi, M. Sun, and J. Zhang Inhibition of peptidyl-prolyl cis/trans isomerase Pin1 induces cell cycle arrest and apoptosis in vascular smooth muscle cells Apoptosis 15 2010 41 54
10. H. Li, S. Wang, T. Zhu, J. Zhou, Q. Xu, Y. Lu, and D. Ma Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression Oncol Rep 16 2006 491 496
11. Q. Ding, L. Huo, J.Y. Yang, W. Xia, Y. Wei, Y. Liao, C.J. Chang, Y. Yang, C.C. Lai, D.F. Lee, C.J. Yen, Y.J. Chen, J.M. Hsu, H.P. Kuo, C.Y. Lin, F.J. Tsai, L.Y. Li, C.H. Tsai, and M.C. Hung Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer Cancer Res 68 2008 6109 6117
12. A. Ryo, A. Hirai, M. Nishi, Y.C. Liou, K. Perrem, S.C. Lin, H. Hirano, S.W. Lee, and I. Aoki A suppressive role of the prolyl isomerase Pin1 in cellular apoptosis mediated by the death-associated protein Daxx J Biol Chem 282 2007 36671 36681
13. D.C. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 2003 8581 8589
14. G.H. Lee, Y.E. Joo, Y.S. Koh, I.J. Chung, Y.K. Park, J.H. Lee, H.S. Kim, S.K. Choi, J.S. Rew, C.S. Park, and S.J. Kim Expression of survivin in gastric cancer and its relationship with tumor angiogenesis Eur J Gastroenterol Hepatol 18 2006 957 963
15. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
16. D.S. O'Connor, D. Grossman, J. Plescia, F. Li, H. Zhang, A. Villa, S. Tognin, P.C. Marchisio, and D.C. Altieri Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin Proc Natl Acad Sci USA 97 2000 13103 13107
17. T. Ito, K. Shiraki, K. Sugimoto, T. Yamanaka, K. Fujikawa, M. Ito, K. Takase, M. Moriyama, H. Kawano, M. Hayashida, T. Nakano, and A. Suzuki Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology 31 2000 1080 1085
18. W.S. Moon, and A.S. Tarnawski Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? Hum Pathol 34 2003 1119 1126
19. H. Marusawa, S. Matsuzawa, K. Welsh, H. Zou, R. Armstrong, I. Tamm, and J.C. Reed HBXIP functions as a cofactor of survivin in apoptosis suppression EMBO J 22 2003 2729 2740
20. R.M. Barrett, T.P. Osborne, and S.P. Wheatley Phosphorylation of survivin at threonine 34 inhibits its mitotic function and enhances its cytoprotective activity Cell Cycle 8 2009 278 283
21. N.R. Wall, D.S. O'Connor, J. Plescia, Y. Pommier, and D.C. Altieri Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis Cancer Res 63 2003 230 235
22. R. Pang, T.K. Lee, R.T. Poon, S.T. Fan, K.B. Wong, Y.L. Kwong, and E. Tse Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis Gastroenterology 132 2007 1088 1103
23. R. Honda, R. Körner, and E.A. Nigg Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis Mol Biol Cell 14 2003 3325 3341
24. T. Dohi, E. Beltrami, N.R. Wall, J. Plescia, and D.C. Altieri Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis J Clin Invest 114 2004 1117 1127
25. P. Fortugno, N.R. Wall, A. Giodini, D.S. O'Connor, J. Plescia, K.M. Padgett, S. Tognin, P.C. Marchisio, and D.C. Altieri Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function J Cell Sci 115 2002 575 585
26. T. Dohi, K. Okada, F. Xia, C.E. Wilford, T. Samuel, K. Welsh, H. Marusawa, H. Zou, R. Armstrong, S. Matsuzawa, G.S. Salvesen, J.C. Reed, and D.C. Altieri An IAP-IAP complex inhibits apoptosis J Biol Chem 279 2004 34087 34090
27. G.M. Wulf, A. Ryo, G.G. Wulf, S.W. Lee, T. Niu, V. Petkova, and K.P. Lu Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1 EMBO J 20 2001 3459 3472
28. G. Ayala, D. Wang, G. Wulf, A. Frolov, R. Li, J. Sowadski, T.M. Wheeler, K.P. Lu, and L. Bao The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer Cancer Res 63 2003 6244 6251
29. L. Bao, A. Kimzey, G. Sauter, J.M. Sowadski, K.P. Lu, and D.G. Wang Prevalent overexpression of prolyl isomerase Pin1 in human cancers Am J Pathol 164 2004 1727 1737
30. E.C. LaCasse, S. Baird, R.G. Korneluk, and A.E. MacKenzie The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 1998 3247 3259
31. K. Tanaka, S. Iwamoto, G. Gon, T. Nohara, M. Iwamoto, and N. Tanigawa Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6 2000 127 134